The University of Utah and The Utah Program for Inherited Neuromuscular Disorders (UPIN) are announced as one of the 26 sites across 13 countries to be conducting the AveXis SMA trial with pre-symptomatic SMA Types 1, 2, and 3 patients. Read more about the trial and the first patient dosed HERE.
UPIN was one of the first centers to join the SMA Care Center Network. This press release describes the network itself and includes a short list of the inaugural centers. Click HERE for the full press release.